J&J pharmaceuticals news
Johnson & Johnson launched its Asia-Pacific Innovation Center, the fourth of J&J's centers. Located in Shanghai with satellite offices in Singapore, Australia and Japan, the center will identify early stage innovations in the areas of pharmaceuticals, consumer healthcare products, and medical devices and diagnostics, and accelerate their development through deals. The center already has six academic partnerships in Australia and China.
J&J's Janssen Australia subsidiary will work with James Cook University in Queensland to study proteins produced by hookworms to treat inflammatory bowel disease (IBD). The center also is extending a collaboration with the University of Queensland (Brisbane, Australia) to explore using peptides derived from spider venom to manage pain. ...